PPARδ ligands have been shown to be neuroprotective in in vivo models of Parkinson’s disease (PD) [13,14], brain ischemia [14,15], spinal cord injury [16] and in streptozotocin-induced experimental diabetes [17]. The gene discussed is PPARD; the disease is Parkinson disease.